COMBINATION OF IL13RALPHA2 CAR T-CELL THERAPY WITH PD-1 IMMUNE CHECKPOINT BLOCKADE FOR TREATMENT OF GLIOBLASTOMA

$236,627FY2017Department of the ArmyDOD

Northwestern University, Evanston IL

Investigators